Pandemic Impact on Treatment

The Covid-19 pandemic has significantly hindered control efforts for human African trypanosomiasis, affecting mobility and funding for national programs. Stigma surrounding the disease has also impacted treatment uptake, although perceptions are gradually improving. Additionally, the oral medication fexinidazole shows promise in treating the disease by targeting the parasite's enzymes, though its exact mechanism remains partially understood.